SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-23-086937
Filing Date
2023-11-14
Accepted
2023-11-14 16:10:46
Documents
14
Period of Report
2023-11-14
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea188304-8k_cormedix.htm   iXBRL 8-K 26450
2 PRESS RELEASE DATED NOVEMBER 14, 2023 ea188304ex99-1_cormedix.htm EX-99.1 55328
3 GRAPHIC ex99-1_001.jpg GRAPHIC 5502
  Complete submission text file 0001213900-23-086937.txt   271313

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE crmd-20231114.xsd EX-101.SCH 3015
5 XBRL LABEL FILE crmd-20231114_lab.xml EX-101.LAB 34240
6 XBRL PRESENTATION FILE crmd-20231114_pre.xml EX-101.PRE 22359
8 EXTRACTED XBRL INSTANCE DOCUMENT ea188304-8k_cormedix_htm.xml XML 3303
Mailing Address 300 CONNELL DRIVE SUITE 4200 BERKELEY HEIGHTS NJ 07922
Business Address 300 CONNELL DRIVE SUITE 4200 BERKELEY HEIGHTS NJ 07922 908-517-9500
CorMedix Inc. (Filer) CIK: 0001410098 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34673 | Film No.: 231406215
SIC: 2834 Pharmaceutical Preparations